Clinical Trial Update: Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

View source ↗

Summary

A clinical trial is evaluating percutaneous thermo-ablation as a treatment for oligometastatic prostate cancer. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Oligometastatic Prostate Cancer (OMPC), Prostate Cancer (Adenocarcinoma) | Status: NOT_YET_RECRUITING